Barry L. Hoeven

Barry L. Hoeven

Barry L. Hoeven

Barry Hoeven is an avid businessman and real estate entrepreneur, who was diagnosed with kidney cancer in 1998.  After diagnosis, the Hoeven's soon realized the lack of funding dedicated to kidney cancer research and other orphan cancers.  As a result, few medical breakthroughs had been made.  The new understanding was the driving force behind the decision to form Kure It and the effort to fund innovative research.  Since then, Barry and his family have been fighting an ongoing battle with cancer, both personally and on the research front.

Kure It has raised more than $4,000,000 since 2007, which has gone directly to cancer researchers.  Contributions from Kure It have helped oncologists study new treatments and the basic biology behind these treatments, in hopes of finding the cure to kidney and other orphan cancers.

In addition to founding Kure It, Hoeven is the Chairman of Westport Properties, Inc. and US Storage Centers, Inc.  Westport Properties, Inc. is a vertically integrated privately held real-estate investment company and owner/developer/operator of over 6,000,000 square feet of income producing commercial real estate comprised of retail, office and primarily self-storage space in thirteen states with an estimated current market value of $800 million.

Barry Hoeven has over 40 years of real estate experience, with a heavy emphasis in all aspects of self-storage and business park development.  His prior work experience included various senior level positions with Public Storage, the Irvine Company and the Colliers-Seeley Company.

On top of the work he does with his companies, Hoeven is involved with other organizations in Southern California, including those that support children and career development.

He is a University of Southern California graduate, having received a Business Degree, with an emphasis in finance and marketing, and an MBA in the Entrepreneurial program at the institution.

Barry has three adult children Hilary, Drew, and Chase.  His two sons Drew and Chase both work for the family company at Westport Properties.  Barry resides in Corona del Mar, CA.

Robert A. Figlin, M.D., F.A.C.P.

Robert A. Figlin, M.D., F.A.C.P.

Robert A. Figlin, M.D., F.A.C.P.

Robert A. Figlin, M.D., F.A.C.P., is the Director of the Division of Hematology/Oncology in the Department of Medicine and the Associate Director for Academic Program Development for the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center.

A nationally recognized leader in genitourinary and thoracic oncology, Dr. Figlin focuses his research on renal cell carcinoma and thoracic malignancies. He established and directs the Kidney Cancer Program at Cedars-Sinai, which aims to understand the biology of kidney cancer and translate that knowledge into new treatments. His leadership in developing novel anticancer drugs that avoid the toxicity associated with standard treatments furthers Cedars-Sinai’s tradition of compassionate patient care

Prior to joining Cedars-Sinai, Dr. Figlin served as the interim Cancer Center Director and Chair of the Department of Medical Oncology and Therapeutics Research at the City of Hope Comprehensive Cancer Center.  Prior to that, Dr. Figlin served as the Henry Alvin and Carrie L. Meinhardt Chair in Urologic Oncology and Professor of Medicine and Urology in the Divisions of Hematology/Oncology and Urologic Oncology at the David Geffen School of Medicine at UCLA.  Dr. Figlin joined the UCLA faculty in 1982 as Assistant Professor of Medicine in the Division of Hematology/Oncology and was appointed Co-Director of the Jonsson Comprehensive Cancer Center’s Oncology Program in 1993. He also held the post of Medical Director of the Thoracic and Genitourinary Oncology Program in the Departments of Medicine, Surgery and Urology, and served as Program Director of Solid Tumor Development Therapeutics within the Cancer Center.

Dr. Figlin serves as editor for the Kidney Cancer Journal, and his studies have appeared in Clinical Cancer Research, theJournal of Clinical Oncology, New England Journal of Medicine, Lancet, and the Journal of Urology, among others. Dr. Figlin received his medical degree from the Medical College of Pennsylvania. He completed his residency in internal medicine at Cedars-Sinai Medical Center and a fellowship in hematology/oncology the David Geffen School of Medicine.

Drew C. Hoeven

Drew C. Hoeven

Drew C. Hoeven

Drew Hoeven has over 10 years of full-time real estate and self storage experience that has included acquisitions, development, construction and operations.  He currently serves as the President of Real Estate at Westport Properties, Inc. and US Storage Centers, Inc. Drew graduated from the University of Southern California with a degree in Policy, Planning & Development.

Drew is presently Secretary of both companies and sits on the Board of Directors and Advisors.  He is currently the Chairman of their Family Business Council, a member of USC Marshall Partners, sits on the next generation board for the Orange County Community Foundation, a member of the NAIOP Young Professionals Group class of 2008 and a NAIOP Forum member. 

Drew joined the Kure It Board of Directors in 2013.  He currently resides in Newport Beach, CA with his wife, Jaime, and his three kids, Hadley, Avery, and Dylan.

Todd Perry

Todd Perry

Todd Perry

Todd’s introduction to Kure It came through his father’s battle with Kidney Cancer, an experience which drove him to find ways to help others with this disease. Todd’s father, Tom, sadly lost his battle with cancer, but through his friendship with Barry Hoeven, Todd learned about Kure It’s mission. It was a cause he wanted to invest in and Todd joined the Board of Directors in 2013.

Todd is the CFO of Briggs Electric, Inc., a family-owned commercial electrical contractor servicing parts of California and Nevada. He graduated from the University of Arizona in 1990 with two degrees - Accounting and Finance. Todd lives in Orange County with his wife, Libby, and his three kids, Lauren, Maggie, and J.T.